Novonesis (Novozymes) B
NSISBC
株式のランク
#1148
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
株価
$70.78
時価総額
$19.67B
変化（1日）
0.96%
変化（1年）
11.63%
国
DK
取引 Novonesis (Novozymes) B (NSISBC)
カテゴリー
Basic Materials
Novonesis (Novozymes) B（NSISBC）の株価履歴
終値の最高値: $69.80 （2026-10-01）
終値の最安値: $58.74 （2024-03-01）
終値の最安値: $58.74 （2024-03-01）
Novonesis (Novozymes) B の株価履歴（2024 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2026 (TTM) | 1.89% |
| 2025 | 7.42% |
| 2024 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $498.80 | 10.86% |
GB
|
|
| $194.46 | 6.85% |
FR
|
|
| $337.21 | 1.02% |
US
|
|
| $287.77 | 4.26% |
US
|
|
| $302.56 | 19.52% |
US
|
